PMID- 24710774 OWN - NLM STAT- MEDLINE DCOM- 20150330 LR - 20151119 IS - 1534-4681 (Electronic) IS - 1068-9265 (Linking) VI - 21 IP - 8 DP - 2014 Aug TI - Minimal clinically important differences in quality of life scores of oral cavity and oropharynx cancer patients. PG - 2773-81 LID - 10.1245/s10434-014-3656-z [doi] AB - BACKGROUND: The minimal clinically important difference (MCID) is defined as the smallest difference in quality of life (QOL) that patients perceive as beneficial and that mandates a change in management. We aimed to determine the MCID among patients with oral cavity and oropharyngeal cancer and to identify domains that are significantly affected during treatment. METHODS: The cohort consisted of 1,011 patients analyzed by a metaanalysis according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. MCID values for the University of Washington Quality of Life Questionnaire (UW-QOLQ) and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC C-30) and Head and Neck-35 questionnaires were calculated by using the distribution-based method. RESULTS: The mean MCID for Global QOL was 13.07 points for the UW-QOLQ and 9.43 in the EORTC C-30 questionnaire. High consistency in the MCID values was found between the two questionnaires examined. Heat map analysis indicated a clinically significant improvement in head and neck-associated domains and in domains associated with general cancer treatment 1 year or more after treatment relative to 3 months after treatment (p < 0.001 and p = 0.016, respectively). In contrast, improvement in general and functional domains was not evident 1 year or more after treatment (p = 0.69). CONCLUSIONS: This study suggests benchmark values for MCID and variation in QOL scores of oral and oropharyngeal cancer patients after treatment. Improvement in head and neck- and general cancer-associated domains may not be translated into a general and functional improvement during the first year of recovery. FAU - Binenbaum, Yoav AU - Binenbaum Y AD - Department of Otolaryngology Head and Neck Surgery, The Technion, Israel Institute of Technology, Haifa, Israel. FAU - Amit, Moran AU - Amit M FAU - Billan, Salem AU - Billan S FAU - Cohen, Jacob T AU - Cohen JT FAU - Gil, Ziv AU - Gil Z LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140408 PL - United States TA - Ann Surg Oncol JT - Annals of surgical oncology JID - 9420840 SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Female MH - Follow-Up Studies MH - Humans MH - Male MH - Meta-Analysis as Topic MH - Middle Aged MH - Mouth Neoplasms/*psychology/*therapy MH - Oropharyngeal Neoplasms/*psychology/*therapy MH - Prognosis MH - *Quality of Life MH - Surveys and Questionnaires MH - Young Adult EDAT- 2014/04/09 06:00 MHDA- 2015/03/31 06:00 CRDT- 2014/04/09 06:00 PHST- 2013/10/31 00:00 [received] PHST- 2014/04/09 06:00 [entrez] PHST- 2014/04/09 06:00 [pubmed] PHST- 2015/03/31 06:00 [medline] AID - 10.1245/s10434-014-3656-z [doi] PST - ppublish SO - Ann Surg Oncol. 2014 Aug;21(8):2773-81. doi: 10.1245/s10434-014-3656-z. Epub 2014 Apr 8.